| 1 |
Gunata M , Parlakpinar H , Acet HA . Melatonin: a review of its potential functions and effects on neurological diseases. Rev Neurol (Paris), 2020, 176: 148- 165.
doi: 10.1016/j.neurol.2019.07.025
|
| 2 |
Tohgi H , Abe T , Takahashi S , Kimura M , Takahashi J , Kikuchi T . Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia. Neurosci Lett, 1992, 141: 9- 12.
doi: 10.1016/0304-3940(92)90322-X
|
| 3 |
Roy J , Wong KY , Aquili L , Uddin MS , Heng BC , Tipoe GL , Wong KH , Fung ML , Lim LW . Role of melatonin in Alzheimer's disease: from preclinical studies to novel melatonin-based therapies. Front Neuroendocrinol, 2022, 65: 100986.
doi: 10.1016/j.yfrne.2022.100986
|
| 4 |
Mishima K , Tozawa T , Satoh K , Matsumoto Y , Hishikawa Y , Okawa M . Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry, 1999, 45: 417- 421.
doi: 10.1016/S0006-3223(97)00510-6
|
| 5 |
Samanta S . Physiological and pharmacological perspectives of melatonin. Arch Physiol Biochem, 2020, 128: 1346- 1367.
|
| 6 |
Chen D , Zhang T , Lee TH . Cellular mechanisms of melatonin: insight from neurodegenerative diseases. Biomolecules, 2020, 10: 1158.
doi: 10.3390/biom10081158
|
| 7 |
Ostrin LA . Ocular and systemic melatonin and the influence of light exposure. Clin Exp Optom, 2019, 102: 99- 108.
doi: 10.1111/cxo.12824
|
| 8 |
Won E , Na KS , Kim YK . Associations between melatonin, neuroinflammation, and brain alterations in depression. Int J Mol Sci, 2021, 23: 305.
doi: 10.3390/ijms23010305
|
| 9 |
Zhai Z , Xie D , Qin T , Zhong Y , Xu Y , Sun T . Effect and mechanism of exogenous melatonin on cognitive deficits in animal models of Alzheimer's disease: a systematic review and meta-analysis. Neuroscience, 2022, 505: 91- 110.
doi: 10.1016/j.neuroscience.2022.09.012
|
| 10 |
Shukla M , Govitrapong P , Boontem P , Reiter RJ , Satayavivad J . Mechanisms of melatonin in alleviating Alzheimer's disease. Curr Neuropharmacol, 2017, 15: 1010- 1031.
|
| 11 |
Li LB , Fan YG , Wu WX , Bai CY , Jia MY , Hu JP , Gao HL , Wang T , Zhong ML , Huang XS , Guo C . Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer's disease. Bioorg Chem, 2022, 128: 106100.
doi: 10.1016/j.bioorg.2022.106100
|
| 12 |
Li Y , Zhang J , Wan J , Liu A , Sun J . Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: a potential therapeutic molecule for Alzheimer's disease. Biomed Pharmacother, 2020, 132: 110887.
doi: 10.1016/j.biopha.2020.110887
|
| 13 |
Wang D , Chen F , Han Z , Yin Z , Ge X , Lei P . Relationship between Amyloid-β deposition and blood-brain barrier dysfunction in Alzheimer's disease. Front Cell Neurosci, 2021, 15: 695479.
doi: 10.3389/fncel.2021.695479
|
| 14 |
Roy J , Tsui KC , Ng J , Fung ML , Lim LW . Regulation of melatonin and neurotransmission in Alzheimer's disease. Int J Mol Sci, 2021, 22: 6841.
doi: 10.3390/ijms22136841
|
| 15 |
Namyen J , Permpoonputtana K , Nopparat C , Tocharus J , Tocharus C , Govitrapong P . Protective effects of melatonin on methamphetamine-induced blood-brain barrier dysfunction in rat model. Neurotox Res, 2020, 37: 640- 660.
doi: 10.1007/s12640-019-00156-1
|
| 16 |
Xu L , Yu H , Sun H , Hu B , Geng Y . Dietary melatonin therapy alleviates the lamina cribrosa damages in patients with mild cognitive impairments: a double-blinded, randomized controlled study. Med Sci Monit, 2020, 26: e923232.
|
| 17 |
Chen D , Mei Y , Kim N , Lan G , Gan CL , Fan F , Zhang T , Xia Y , Wang L , Lin C , Ke F , Zhou XZ , Lu KP , Lee TH . Melatonin directly binds and inhibits death-associated protein kinase 1 function in Alzheimer's disease. J Pineal Res, 2020, 69: e12665.
|
| 18 |
Das R , Balmik AA , Chinnathambi S . Melatonin reduces GSK3β-mediated tau phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation. ASN Neuro, 2020, 12: 1759091420981204.
|
| 19 |
Cardinali DP . Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne), 2019, 10: 480.
doi: 10.3389/fendo.2019.00480
|
| 20 |
Reiter RJ , Mayo JC , Tan DX , Sainz RM , Alatorre-Jimenez M , Qin L . Melatonin as an antioxidant: under promises but over delivers. J Pineal Res, 2016, 61: 253- 278.
doi: 10.1111/jpi.12360
|
| 21 |
Jauhari A , Baranov SV , Suofu Y , Kim J , Singh T , Yablonska S , Li F , Wang X , Oberly P , Minnigh MB , Poloyac SM , Carlisle DL , Friedlander RM . Melatonin inhibits cytosolic mitochondrial DNA-induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J Clin Invest, 2020, 130: 3124- 3136.
doi: 10.1172/JCI135026
|
| 22 |
Tan DX , Manchester LC , Qin L , Reiter RJ . Melatonin: a mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int J Mol Sci, 2016, 17: 2124.
doi: 10.3390/ijms17122124
|
| 23 |
Reiter RJ , Melchiorri D , Sewerynek E , Poeggeler B , Barlow-Walden L , Chuang J , Ortiz GG , Acuña-Castroviejo D . A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res, 1995, 18: 1- 11.
doi: 10.1111/j.1600-079X.1995.tb00133.x
|
| 24 |
Pandi-Perumal SR , BaHammam AS , Brown GM , Spence DW , Bharti VK , Kaur C , Hardeland R , Cardinali DP . Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotox Res, 2013, 23: 267- 300.
doi: 10.1007/s12640-012-9337-4
|
| 25 |
Kvetnoy I , Ivanov D , Mironova E , Evsyukova I , Nasyrov R , Kvetnaia T , Polyakova V . Melatonin as the cornerstone of neuroimmunoendocrinology. Int J Mol Sci, 2022, 23: 1835.
doi: 10.3390/ijms23031835
|
| 26 |
Hardeland R . Melatonin and inflammation-story of a double-edged blade. J Pineal Res, 2018, 65: e12525.
doi: 10.1111/jpi.12525
|
| 27 |
Hardeland R . Aging, melatonin, and the pro-and anti-inflammatory networks. Int J Mol Sci, 2019, 20: 1223.
doi: 10.3390/ijms20051223
|
| 28 |
Fan L , Zhaohong X , Xiangxue W , Yingying X , Xiao Z , Xiaoyan Z , Jieke Y , Chao L . Melatonin ameliorates the progression of Alzheimer's disease by inducing TFEB nuclear translocation, promoting mitophagy, and regulating NLRP3 inflammasome activity. Biomed Res Int, 2022, 8099459.
|
| 29 |
Labban S , Alghamdi BS , Alshehri FS , Kurdi M . Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer's disease. Behav Brain Res, 2021, 402: 113100.
doi: 10.1016/j.bbr.2020.113100
|
| 30 |
Agrawal R , Tyagi E , Shukla R , Nath C . Effect of insulin and melatonin on acetylcholinesterase activity in the brain of amnesic mice. Behav Brain Res, 2008, 189: 381- 386.
doi: 10.1016/j.bbr.2008.01.015
|
| 31 |
Hossain MF , Uddin MS , Uddin GMS , Sumsuzzman DM , Islam MS , Barreto GE , Mathew B , Ashraf GM . Melatonin in Alzheimer's disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer's neuropathology. Mol Neurobiol, 2019, 56: 8255- 8276.
doi: 10.1007/s12035-019-01660-3
|
| 32 |
Hossain MF , Wang N , Chen R , Li S , Roy J , Uddin MG , Li Z , Lim LW , Song YQ . Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer's disease neuropathology. Ageing Res Rev, 2021, 67: 101304.
doi: 10.1016/j.arr.2021.101304
|
| 33 |
Luo F , Sandhu AF , Rungratanawanich W , Williams GE , Akbar M , Zhou S , Song BJ , Wang X . Melatonin and autophagy in aging-related neurodegenerative diseases. Int J Mol Sci, 2020, 21: 7174.
doi: 10.3390/ijms21197174
|
| 34 |
Jenwitheesuk A , Nopparat C , Mukda S , Wongchitrat P , Govitrapong P . Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci, 2014, 15: 16848- 16884.
doi: 10.3390/ijms150916848
|
| 35 |
Chen C , Yang C , Wang J , Huang X , Yu H , Li S , Li S , Zhang Z , Liu J , Yang X , Liu GP . Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer's disease. J Pineal Res, 2021, 71: e12774.
doi: 10.1111/jpi.12774
|
| 36 |
Rudnitskaya EA , Maksimova KY , Muraleva NA , Logvinov SV , Yanshole LV , Kolosova NG , Stefanova NA . Beneficial effects of melatonin in a rat model of sporadic Alzheimer's disease. Biogerontology, 2015, 16: 303- 316.
doi: 10.1007/s10522-014-9547-7
|
| 37 |
Tang H , Ma M , Wu Y , Deng MF , Hu F , Almansoub HAMM , Huang HZ , Wang DQ , Zhou LT , Wei N , Man H , Lu Y , Liu D , Zhu LQ . Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer's disease via C/EBPα/miR-125b pathway. Aging Cell, 2019, 18: e12902.
doi: 10.1111/acel.12902
|
| 38 |
Özsimsek A , Övey IS . Potential effects of melatonin on TRPA1 channels in the prevention and treatment of Alzheimer's disease. Noro Psikiyatr Ars, 2022, 59: 188- 192.
|
| 39 |
Argueta J , Solís-Chagoyán H , Estrada-Reyes R , Constantino-Jonapa LA , Oikawa-Sala J , Velázquez-Moctezuma J , Benítez-King G . Further evidence of the melatonin calmodulin interaction: effect on CaMK Ⅱ activity. Int J Mol Sci, 2022, 23: 2479.
doi: 10.3390/ijms23052479
|
| 40 |
Holth JK , Fritschi SK , Wang C , Pedersen NP , Cirrito JR , Mahan TE , Finn MB , Manis M , Geerling JC , Fuller PM , Lucey BP , Holtzman DM . The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science, 2019, 363: 880- 884.
doi: 10.1126/science.aav2546
|
| 41 |
Azzi A , Dallmann R , Casserly A , Rehrauer H , Patrignani A , Maier B , Kramer A , Brown SA . Circadian behavior is light-reprogrammed by plastic DNA methylation. Nat Neurosci, 2014, 17: 377- 382.
doi: 10.1038/nn.3651
|
| 42 |
Uddin MS , Tewari D , Mamun AA , Kabir MT , Niaz K , Wahed MⅡ , Barreto GE , Ashraf GM . Circadian and sleep dysfunction in Alzheimer's disease. Ageing Res Rev, 2020, 60: 101046.
doi: 10.1016/j.arr.2020.101046
|
| 43 |
Tranah GJ , Blackwell T , Stone KL , Ancoli-Israel S , Paudel ML , Ensrud KE , Cauley JA , Redline S , Hillier TA , Cummings SR , Yaffe K , SOF Research Group . Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol, 2011, 70: 722- 732.
doi: 10.1002/ana.22468
|
| 44 |
Leng Y , Musiek ES , Hu K , Cappuccio FP , Yaffe K . Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol, 2019, 18: 307- 318.
doi: 10.1016/S1474-4422(18)30461-7
|
| 45 |
Rogers-Soeder TS , Blackwell T , Yaffe K , Ancoli-Israel S , Redline S , Cauley JA , Ensrud KE , Paudel M , Barrett-Connor E , LeBlanc E , Stone K , Lane NE , Tranah G , Osteoporotic Fractures in Men Study Research Group . Rest-activity rhythms and cognitive decline in older men: the osteoporotic fractures in men sleep study. J Am Geriatr Soc, 2018, 66: 2136- 2143.
doi: 10.1111/jgs.15555
|
| 46 |
Reiter RJ , Sharma R , Cucielo MS , Tan DX , Rosales-Corral S , Gancitano G , de Almeida Chuffa LG . Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm. Cell Mol Life Sci, 2023, 80: 88.
doi: 10.1007/s00018-023-04736-5
|
| 47 |
Nedergaard M , Goldman SA . Glymphatic failure as a final common pathway to dementia. Science, 2020, 370: 50- 56.
doi: 10.1126/science.abb8739
|
| 48 |
Roth T , Nir T , Zisapel N . Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial. Nat Sci Sleep, 2015, 7: 13- 23.
|
| 49 |
Lesser GT . Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama study. Neurology, 2012, 78: 1280.
|
| 50 |
Yin F . Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J, 2023, 290: 1420- 1453.
doi: 10.1111/febs.16344
|
| 51 |
Matsuzaki T , Sasaki K , Hata J , Hirakawa Y , Fujimi K , Ninomiya T , Suzuki SO , Kanba S , Kiyohara Y , Iwaki T . Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama study. Neurology, 2011, 77: 1068- 1075.
doi: 10.1212/WNL.0b013e31822e145d
|
| 52 |
Li Y , Xu Z . Effects of melatonin supplementation on insulin levels and insulin resistance: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res, 2021, 53: 616- 624.
doi: 10.1055/a-1544-8181
|
| 53 |
Kellar D , Craft S . Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol, 2020, 19: 758- 766.
doi: 10.1016/S1474-4422(20)30231-3
|
| 54 |
Reiter RJ , Rosales-Corral S , Tan DX , Jou MJ , Galano A , Xu B . Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas. Cell Mol Life Sci, 2017, 74: 3863- 3881.
doi: 10.1007/s00018-017-2609-7
|